Ray Blanco’s FDA Trader

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

It is designed to alert you to breakout moves could ultimately drive huge stock market gains...

Important: Flash Alert

Yesterday, this stock was down over 10% because a clinical study did not show positive results. This was a small, early stage study for a disease called rheumatoid arthritis. It's a non-event. Clever investors use non-events like this to bang stocks down all the time. I know their tactics from when I managed a $5 billion hedge fund.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!


Ray Blanco’s FDA Trader

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

LoginGet Access

Paul Mampilly

Back when Paul Mampilly was growing up in India, nobody talked about the stock market. Yet as a kid, Paul read voraciously about the Great Crash of 1929 and found it fascinating.

When he turned 18, he came to the United States by himself. Since then, he’s had close to 25 years of investment...

View More By Paul Mampilly

LEARN TO TRADE LIKE A PRO WITH THE SEVEN FIGURE PODCAST! [CLICK HERE]